Abstract
Bayraktaroglu, A.V., Comparison of Exercise Capacity, Activity Self Efficacy,
Cognitive Function and Fatigue Levels in Patients with COVID-19 Infection
Followed in Hospital and at Home in the Post COVID Period with Non-Infected
Individuals, Hacettepe University, Graduate School of Health Sciences,
Cardiopulmonary Rehabilitation Programme, Master of Science Thesis, Ankara,
2023. The Novel Coronavirus (SARS-CoV-2) disease may result in different levels
from mild to severe such as acute respiratory distress syndrome and multi-organ failure
or asymptomatic. Some patients may also be symptomatic in the post-COVID period.
The aim of this study was compare patients who had COVID-19 infection in the
hospital and at home with non-infected individuals in terms of exercise capacity,
activity-self efficacy, cognitive function and fatigue in the post-COVID period. A total
of 45 individuals with COVID-19 (20 individuals in hospital and 25 individuals at
home) and 23 non-infected individuals were included in the study. The demographic
characteristics of the individuals were recorded. While the individuals were similar in
terms of gender, the mean in terms of age of those who spent in the hospital were
higher (p<0.05). Exercise capacity by using 6 Minute Step Test (6MST), activity-self
efficacy by using Occupational Self-Assesment (OSA), cognitive function by using
The Cognitive Failures Questionnaire (CFQ), fatigue by using Brief Fatigue Inventory
(BFI), activities of daily living (ADL) by using The London Chest ADL Scale
(LCADL), physical activity by using International Physical Activity Questionnaire
(IPAQ) were assessed. Group those who spent in the hospital had a higher resting heart
rate (p<0.05). When individuals who spend in the hospital and at home are grouped as
who have had COVID-19 had lower post exercise oxygen saturation, higher perception
of post exercise muscle fatigue and higher both resting and post exercise fatigue and
dspnea perception (p<0.05). Activity-self efficacy, cognitive function and physical
activity levels were similar (p>0.05). When individuals who spend in the hospital and
at home are grouped as who have had COVID-19 had according to BFI fatigue, the
effect of fatigue on general activity and according to LCADL dyspnea perception
during physical activity were found to be high (p<0.05). In conclusion; patients with
COVID-19 may experience prolonged fatigue, their ADL levels may be affected in the
post-COVID period. While resting cardiorespiratory parameters may be affected,
dyspnea, fatigue and muscle fatigue perception may be higher after the exercise. When
planning the rehabilitation program in the post-COVID period, symptoms such as
fatigue, dyspnea should be considered, regardless of whether they are at home or in
the hospital.
xmlui.mirage2.itemSummaryView.Collections
xmlui.dri2xhtml.METS-1.0.item-citation
1. To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, et al. Lessons learned 1
year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg
Microbes Infect. 2021;10(1):507-35.
2. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed.
2020;91(1):157-60.
3. World Health Organization, COVID-19 weekly epidemiological update 21
December 2022 [Internet]. 2022 [Erişim tarihi 25 Aralık 2022]. Erişim adresi:
https://www.who.int/publications/m/item/covid-19-weekly-epidemiological update---21-december-2022
4. Bakanlığı S. Genel Koronavirüs Tablosu 2022 [Internet]. 2022 [Erişim tarihi 25
Aralık 2022]. Erişim adresi: https://covid19.saglik.gov.tr/TR-66935/genel koronavirus-tablosu.html
5. Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, et
al. Development and validation of a prediction model for 30-day mortality in
hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax.
2021;76(9):920-9.
6. Prescott HC. Outcomes for Patients Following Hospitalization for COVID-19.
Jama. 2021;325(15):1511-2.
7. van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. Post acute and long-COVID-19 symptoms in patients with mild diseases: a
systematic review. Fam Pract. 2022;39(1):159-67.
8. Matias-Guiu JA, Delgado-Alonso C, Díez-Cirarda M, Martínez-Petit Á, Oliver Mas S, Delgado-Álvarez A, et al. Neuropsychological predictors of fatigue in
post-COVID syndrome. Journal of clinical medicine. 2022;11(13):3886.
9. Landsman JA, Verheij NP, Alma MA, van den Boogaard J, Luning-Koster M,
Evenboer KE, et al. [COVID-19: recovering at home is not easy]. Ned Tijdschr
Geneeskd. 2020;164.
10. Edemekong PF, Bomgaars DL, Sukumaran S, Schoo C. Activities of Daily
Living. StatPearls. 2022.
11. Fernández-de-Las-Peñas C, Martín-Guerrero JD, Navarro-Pardo E, Rodríguez Jiménez J, Pellicer-Valero OJ. Post-COVID functional limitations on daily
living activities are associated with symptoms experienced at the acute phase of
SARS-CoV-2 infection and internal care unit admission: A multicenter study.
Journal of Infection. 2022;84(2):248-88.
12. Goldstein RE. Exercise Capacity. Clinical Methods: The History, Physical, and
Laboratory Examinations. 1990.
13. Magdy DM, Metwally A, Tawab DA, Hassan SA, Makboul M, Farghaly S.
Long-term COVID-19 effects on pulmonary function, exercise capacity, and
health status. Ann Thorac Med. 2022;17(1):28-36.
77
14. Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM.
Education and Cognitive Functioning Across the Life Span. Psychol Sci Public
Interest. 2020;21(1):6-41.
15. Méndez R, Balanzá-Martínez V, Luperdi SC, Estrada I, Latorre A, González Jiménez P, et al. Short-term neuropsychiatric outcomes and quality of life in
COVID-19 survivors. J Intern Med. 2021;290(3):621-31.
16. Clemente-Suárez VJ, Beltrán-Velasco AI, Ramos-Campo DJ, Mielgo-Ayuso J,
Nikolaidis PA, Belando N, et al. Physical activity and COVID-19. The basis for
an efficient intervention in times of COVID-19 pandemic. Physiology &
behavior. 2022;244:113667.
17. Lee SW, Lee J, Moon SY, Jin HY, Yang JM, Ogino S, et al. Physical activity
and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID 19 related mortality in South Korea: a nationwide cohort study. British Journal
of Sports Medicine. 2022;56(16):901-12.
18. Tanriverdi A, Savci S, Kahraman BO, Ozpelit E. Extrapulmonary features of
post-COVID-19 patients: muscle function, physical activity, mood, and sleep
quality. Irish Journal of Medical Science (1971-). 2022;191(3):969-75.
19. Yıldırım M, Güler A. COVID-19 severity, self-efficacy, knowledge, preventive
behaviors, and mental health in Turkey. Death Stud. 2022;46(4):979-86.
20. Zhou Y, Yang Y, Huang J, Jiang S, Du L. Advances in MERS-CoV Vaccines
and Therapeutics Based on the Receptor-Binding Domain. Viruses. 2019;11(1).
21. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev
Microbiol. 2019;17(3):181-92.
22. Koronavirüs [Internet]. 2019 [Erişim tarihi 8 Ocak 2023]. Erişim adresi:
https://tr.wikipedia.org/wiki/Koronavir%C3%BCs.
23. Coronaviruses – a general introduction [Internet]. 2020 [Erişim tarihi 1 Ocak
2023]. Erişim adresi: https://www.cebm.net/covid-19/coronaviruses-a-general introduction/.
24. Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, et al. The First 75 Days of
Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention,
and Treatment. Int J Environ Res Public Health. 2020;17(7).
25. Kolifarhood G, Aghaali M, Mozafar Saadati H, Taherpour N, Rahimi S, Izadi
N, et al. Epidemiological and Clinical Aspects of COVID-19; a Narrative
Review. Arch Acad Emerg Med. 2020;8(1):e41.
26. Middle East respiratory syndrome coronavirus (MERS-CoV) [Internet]. 2022
[Erişim tarihi 15 Ocak 2023]. Erişim adresi:
https://www.who.int/emergencies/mers-cov/en/
27. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection:
Origin, transmission, and characteristics of human coronaviruses. J Adv Res.
2020;24:91-8.
78
28. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus
from patients with pneumonia in China, 2019. New England journal of
medicine. 2020.
29. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia
outbreak associated with a new coronavirus of probable bat origin. nature.
2020;579(7798):270-3.
30. Gorbalenya AE, Baker SC, Baric R, Groot RJd, Drosten C, Gulyaeva AA, et al.
Severe acute respiratory syndrome-related coronavirus: The species and its
viruses–a statement of the Coronavirus Study Group. 2020.
31. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens.
2020;9(3).
32. Öztan G, Issever H. Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve
Genomik Karakterizasyonu. Istanbul University Institute of Health Sciences
Journal of Advanced Research in Health Sciences. 2020;3.
33. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID 19. Nat Rev Microbiol. 2021;19(3):141-54.
34. Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar
JR, et al. SARS-CoV-2 was already spreading in France in late December 2019.
Int J Antimicrob Agents. 2020;55(6):106006.
35. Homma Y, Katsuta T, Oka H, Inoue K, Toyoshima C, Iwaki H, et al. The
incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of
other strains. J Infect. 2021;83(2):e15-e7.
36. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J
Pediatr. 2020;87(4):281-6.
37. Coronavirus (Koronavirus) Belirtileri Nelerdir? [Internet]. 2020 [Erişim tarihi
15 Ocak 2023]. Erişim adresi: https://www.anadolusaglik.org/blog/corona korona-virusu-nedir-belirtileri-nelerdir
38. Molteni E, Sudre CH, Canas LDS, Bhopal SS, Hughes RC, Chen L, et al. Illness
characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta
variant. Children. 2022;9(5):652.
39. Del Rio C, Malani PN. COVID-19 in 2022-The Beginning of the End or the
End of the Beginning? JAMA. 2022;327(24):2389-90.
40. (WHO) WHO. TAG-VE statement on Omicron sublineages BQ.1 and XBB.
2022.
41. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features,
Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. 2022.
42. Bakanlığı TCS. COVID-19 (SARS-CoV-2 ENFEKSİYONU) GENEL
BİLGİLER, EPİDEMİYOLOJİ VE TANI; 2020.
43. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC.
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus
Disease 2019 (COVID-19): A Review. Jama. 2020;324(8):782-93.
79
44. Bakanlığı TCS. COVID-19(SARS-CoV-2 Enfeksiyonu) Erişkin Hasta
Tedavisi; 2022.
45. Tsang HF, Chan LWC, Cho WCS, Yu ACS, Yim AKY, Chan AKC, et al. An
update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention
and treatment strategies. Expert Rev Anti Infect Ther. 2021;19(7):877-88.
46. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID 19): current status and future perspectives. Int J Antimicrob Agents.
2020;55(5):105951.
47. Yong E. Long-haulers are redefining COVID-19. The Atlantic. 2020.
48. LongCovidSOS [Internet]. 2020 [Erişim tarihi 15 Ocak 2023]. Erişim adresi:
https://www.longcovidsos.org/
49. Garner P. Paul Garner: For 7 weeks I have been through a roller coaster of ill
health, extreme emotions, and utter exhaustion. British Medical Journal (BMJ).
2020.
50. Perego E, Long COVID [Internet]. 2020 [Erişim tarihi 15 Ocak 2023]. Erişim
adresi: https://twitter.com/elisaperego78/status/1263172084055838721?s=20
51. Keay L. Long-term COVID Warning: ICU Doctor Reports Having Coronavirus
Symptoms for Three Months.. 25 June. Available from: Sky News. 2020.
52. (NICE) NIfHaCE. COVID-19 rapid guideline: managing the long-term effects
of COVID-19. 2020.
53. Altmann DM, Boyton RJ. Decoding the unknowns in long covid. Bmj.
2021;372:n132.
54. Raveendran A. Long COVID-19: Challenges in the diagnosis and proposed
diagnostic criteria. Diabetes & Metabolic Syndrome. 2021;15(1):145.
55. Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V,
Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute
COVID, Long COVID, Persistent Post-COVID): An Integrative Classification.
Int J Environ Res Public Health. 2021;18(5).
56. Assaf G, Davis H, McCorkell L. COVID-19 Prolonged Symptoms Survey Analysis Report. 2020.
57. Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et
al. Symptoms, complications and management of long COVID: a review.
Journal of the Royal Society of Medicine. 2021;114(9):428-42.
58. Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety
of persistent symptoms among patients with COVID-19: a systematic review.
JAMA network open. 2021;4(5):e2111417-e.
59. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. 'Long COVID': a cross-sectional study of persisting symptoms, biomarker and
imaging abnormalities following hospitalisation for COVID-19. Thorax.
2021;76(4):396-8.
80
60. Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V,
Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post COVID-19 symptoms in hospitalized and non-hospitalized COVID-19
survivors: A systematic review and meta-analysis. European journal of internal
medicine. 2021;92:55-70.
61. Martin I, Braem F, Baudet L, Poncin W, Fizaine S, Aboubakar F, et al. Follow up of functional exercise capacity in patients with COVID-19: It is improved
by telerehabilitation. Respir Med. 2021;183:106438.
62. Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID 19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase
from a European Respiratory Society and American Thoracic Society coordinated International Task Force. Eur Respir J. 2020;56(6).
63. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al.
Persistent fatigue following SARS-CoV-2 infection is common and
independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.
64. Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, Rasch-Halvorsen Ø,
Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months
after COVID-19 hospitalisation. European Respiratory Journal. 2021;58(2).
65. Damanti S, Ramirez GA, Bozzolo EP, Rovere‐Querini P, De Lorenzo R,
Magnaghi C, et al. Six‐month respiratory outcomes and exercise capacity of
COVID‐19 acute respiratory failure patients treated with continuous positive
airway pressure. Internal Medicine Journal. 2021;51(11):1810-5.
66. Clavario P, De Marzo V, Lotti R, Barbara C, Porcile A, Russo C, et al.
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow up. International journal of cardiology. 2021;340:113-8.
67. Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al.
Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long term persistent symptoms and functional impairment similar to patients with
severe COVID-19: a cautionary tale during a global pandemic. Clinical
Infectious Diseases. 2021;73(3):e826-e9.
68. Lambert N. COVID-19 “Long Hauler” Symptoms Survey ReportSurvivor
Corps. 2020.
69. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and
characterisation of post-COVID-19 manifestations. Int J Clin Pract.
2021;75(3):e13746.
70. Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come?
Med Hypotheses. 2021;146:110469.
71. Harrison M, Briggs-Price S, Gerlis C, Gardiner N, Singh S, Daynes E. The
interaction between fatigue and anxiety in people post hospitalisation with
COVID-19. Physiotherapy. 2022;114:e202-e3.
72. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and
Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A
Population-Based Study. Int J Environ Res Public Health. 2021;18(4).
81
73. Van Herck M, Goërtz YM, Houben-Wilke S, Machado FV, Meys R,
Delbressine JM, et al. Severe Fatigue in Long COVID: Web-Based Quantitative
Follow-up Study in Members of Online Long COVID Support Groups. Journal
of Medical Internet Research. 2021;23(9):e30274.
74. Johnsen S, Sattler SM, Miskowiak KW, Kunalan K, Victor A, Pedersen L, et
al. Descriptive analysis of long COVID sequelae identified in a
multidisciplinary clinic serving hospitalised and non-hospitalised patients. ERJ
Open Res. 2021;7(3).
75. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT,
et al. Long-term cognitive impairment after critical illness. New England
Journal of Medicine. 2013;369(14):1306-16.
76. Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment
of cognitive function in patients after COVID-19 infection. JAMA network
open. 2021;4(10):e2130645-e.
77. Ferrucci R, Dini M, Groppo E, Rosci C, Reitano MR, Bai F, et al. Long-lasting
cognitive abnormalities after COVID-19. Brain Sciences. 2021;11(2):235.
78. Mohamed-Hussein A, Amin M, Makhlouf H, Makhlouf N, Galal I, Abd-Elaal
H, et al. Non-hospitalised COVID-19 patients have more frequent long COVID 19 symptoms. The International Journal of Tuberculosis and Lung Disease.
2021;25(9):732-7.
79. Bandura A. Self-Efficacy. The Corsini Encyclopedia of Psychology. p. 1-3.
80. Bandura A. Self-efficacy: The exercise of control: Macmillan; 1997.
81. Pekçetin S ea. Multipl Skleroz Hastalarında Algılanan Yorgunluğun Aktivite Rol Yeterliliği ile İlişkisi. Ergoterapi ve Rehabilitasyon Dergisi. 2019;7(2):79-
84.
82. Poyraz B, Poyraz CA, Olgun Y, Gürel Ö, Alkan S, Özdemir YE, et al.
Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry
Res. 2021;295:113604.
83. Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F,
et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic
stress disorder after the outbreak of the COVID-19. J Neurovirol.
2021;27(1):154-9.
84. Duggal P, Penson T, Manley HN, Vergara C, Munday RM, Duchen D, et al.
Post-sequelae symptoms and comorbidities after COVID-19. J Med Virol.
2022;94(5):2060-6.
85. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms
1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based
cohort study. Thorax. 2021;76(4):405-7.
86. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et
al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31.
82
87. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences
of COVID-19 in patients discharged from hospital: a cohort study. Lancet.
2021;397(10270):220-32.
88. Anaya J-M, Rojas M, Salinas ML, Rodríguez Y, Roa G, Lozano M, et al. Post COVID syndrome. A case series and comprehensive review. Autoimmunity
reviews. 2021;20(11):102947.
89. Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro
F, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital
organs, exercise capacity, cognition, quality of life and mental health, post hospital discharge. EClinicalMedicine. 2021;31:100683.
90. Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, et al.
Rehabilitation of patients post-COVID-19 infection: a literature review. J Int
Med Res. 2020;48(8):300060520948382.
91. Yong SJ. Long COVID or post-COVID-19 syndrome: putative
pathophysiology, risk factors, and treatments. Infect Dis (Lond).
2021;53(10):737-54.
92. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of
post-acute covid-19 in primary care. Bmj. 2020;370:m3026.
93. Soril LJ, Damant RW, Lam GY, Smith MP, Weatherald J, Bourbeau J, et al.
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A
rapid review of the literature. Respiratory medicine. 2022:106782.
94. Puchner B, Sahanic S, Kirchmair R, Pizzini A, Sonnweber B, Wöll E, et al.
Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19:
an observational cohort study. Eur J Phys Rehabil Med. 2021;57(2):189-98.
95. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in
elderly patients with COVID-19: A randomized controlled study. Complement
Ther Clin Pract. 2020;39:101166.
96. Woollett P SC, Howden E, Butler N, Fon A, Lewthwaite H. COVID-19
Exercise Guidelines, 2022.
97. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al.
Characterizing long COVID in an international cohort: 7 months of symptoms
and their impact. Available at SSRN 3820561. 2021.
98. Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long
covid. Bmj. 2021;373:n853.
99. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features,
Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. 2022.
100. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon
SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and
non-viral pathogens: prospective cohort study. Bmj. 2006;333(7568):575.
101. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post discharge persistent symptoms and health-related quality of life after
hospitalization for COVID-19. Journal of Infection. 2020;81(6):e4-e6.
83
102. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al.
Patient outcomes after hospitalisation with COVID-19 and implications for
follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399-401.
103. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms
1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based
cohort study. Thorax. 2021;76(4):405-7.
104. Arcuri JF, Borghi-Silva A, Labadessa IG, Sentanin AC, Candolo C, Pires Di
Lorenzo VA. Validity and Reliability of the 6-Minute Step Test in Healthy
Individuals: A Cross-sectional Study. Clin J Sport Med. 2016;26(1):69-75.
105. Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index:
A Critical Review of Clinimetric Properties. Psychother Psychosom.
2022;91(1):8-35.
106. WHO, A healthy lifestyle - WHO recommendations [Internet]. 2010 [Erişim
tarihi 15 Ocak 2023]. Erişim adresi: https://www.who.int/europe/news room/fact-sheets/item/a-healthy-lifestyle---who-recommendations
107. Calik-Kutukcu E, Arikan H, Saglam M, Vardar-Yagli N, Oksuz C, Inal-Ince D,
et al. Arm strength training improves activities of daily living and occupational
performance in patients with COPD. Clin Respir J. 2017;11(6):820-32.
108. Albuquerque VS, Corso SD, Amaral DPd, Oliveira TMDd, Souza GF, Souza
RNSd, et al. Normative values and reference equation for the six-minute step
test to evaluate functional exercise capacity: a multicenter study. Jornal
Brasileiro de Pneumologia. 2022;48.
109. Azak A, ÇINAR S. Lenfomalı (hodgkin ve non-hodgkin) hastalarda yorgunluk
sendromu ve etkileyen faktörler. Türk Hematoloji Onkoloji Dergisi.
2005;15(2):78-85.
110. Ekici G, Uysal SA, Altuntaş O. The validity and reliability of Cognitive failures
questionnaire in university students. Fizyoterapi Rehabilitasyon.
2016;27(2):55-60.
111. Saka S, Savcı S, Kütükcü EÇ, Sağlam M, Yağlı NV, İnce Dİ, et al. Validity and
reliability of the Turkish version of the London chest activity of daily living
scale in obstructive lung diseases. Turkish Thoracic Journal. 2020;21(2):116.
112. Baron K, Kielhofner G. A User's Manual for the Occupational Self Assessment
(OSA)(Version 2.2): Model of Human Occupational Clearinghouse,
Department of Occupational …; 2006.
113. Saglam M, Arikan H, Savci S, Inal-Ince D, Bosnak-Guclu M, Karabulut E, et
al. International physical activity questionnaire: reliability and validity of the
Turkish version. Percept Mot Skills. 2010;111(1):278-84.
114. Meghanathan N. Assortativity Analysis of Real-World Network Graphs based
on Centrality Metrics. Comput Inf Sci. 2016;9(3):7-25.
115. Sivan M, Parkin A, Makower S, Greenwood DC. Post-COVID syndrome
symptoms, functional disability, and clinical severity phenotypes in
hospitalized and nonhospitalized individuals: A cross-sectional evaluation from
84
a community COVID rehabilitation service. Journal of Medical Virology.
2022;94(4):1419-27.
116. Silverio A, Di Maio M, Citro R, Esposito L, Iuliano G, Bellino M, et al.
Cardiovascular risk factors and mortality in hospitalized patients with COVID 19: systematic review and meta-analysis of 45 studies and 18,300 patients.
BMC Cardiovasc Disord. 2021;21(1):23.
117. Gao X, Dong Q. A Bayesian framework for estimating the risk ratio of
hospitalization for people with comorbidity infected by SARS-CoV-2 virus.
Journal of the American Medical Informatics Association. 2021;28(3):472-6.
118. Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA,
et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med.
2021;27(9):1607-13.
119. Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange
SJ, et al. Body Mass Index and Risk for COVID-19-Related Hospitalization,
Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death -
United States, March-December 2020. MMWR Morb Mortal Wkly Rep.
2021;70(10):355-61.
120. Haddad C, Bou Malhab S, Sacre H, Salameh P. Smoking and COVID-19: A
Scoping Review. Tob Use Insights. 2021;14:1179173x21994612.
121. Patanavanich R, Glantz SA. Smoking Is Associated With COVID-19
Progression: A Meta-analysis. Nicotine Tob Res. 2020;22(9):1653-6.
122. Puebla Neira D, Watts A, Seashore J, Polychronopoulou E, Kuo YF, Sharma G.
Smoking and risk of COVID-19 hospitalization. Respir Med. 2021;182:106414.
123. Valenzuela PL, Simpson RJ, Castillo-García A, Lucia A. Physical activity: A
coadjuvant treatment to COVID-19 vaccination? Brain Behav Immun.
2021;94:1-3.
124. Barrea L, Verde L, Grant WB, Frias-Toral E, Sarno G, Vetrani C, et al. Vitamin
D: A Role Also in Long COVID-19? Nutrients. 2022;14(8).
125. Catalano A, Iacopetta D, Ceramella J, Maio ACD, Basile G, Giuzio F, et al. Are
Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and
Treatment? Foods. 2022;11(18):2884.
126. Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al.
Impact of COVID-19 vaccination on the risk of developing long-COVID and
on existing long-COVID symptoms: A systematic review. EClinicalMedicine.
2022;53:101624.
127. Bradbury CA, McQuilten Z. Anticoagulation in COVID-19. The Lancet.
2022;399(10319):5-7.
128. Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long COVID) and their respective potential therapies. Rev Med Virol.
2022;32(4):e2315.
129. Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A,
Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19
85
Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public
Health. 2021;18(10).
130. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and
cognitive impairment in Post-COVID-19 Syndrome: A systematic review and
meta-analysis. Brain Behav Immun. 2022;101:93-135.
131. Saeed S, Rajani R. The association of pre-existing comorbid conditions with
COVID-19 severity and post-COVID complications; insights from South Asia.
Pak J Med Sci. 2022;38(3Part-I):439-41.
132. Horwitz LI, Garry K, Prete AM, Sharma S, Mendoza F, Kahan T, et al. Six Month Outcomes in Patients Hospitalized with Severe COVID-19. J Gen Intern
Med. 2021;36(12):3772-7.
133. Katsarou M-S, Iasonidou E, Osarogue A, Kalafatis E, Stefanatou M, Pappa S,
et al. The Greek Collaborative Long COVID Study: Non-Hospitalized and
Hospitalized Patients Share Similar Symptom Patterns. Journal of Personalized
Medicine. 2022;12(6):987.
134. Fernández-de-Las-Peñas C, Gómez-Mayordomo V, de-la-Llave-Rincón AI,
Palacios-Ceña M, Rodríguez-Jiménez J, Florencio LL, et al. Anxiety,
depression and poor sleep quality as long-term post-COVID sequelae in
previously hospitalized patients: A multicenter study. J Infect. 2021;83(4):496-
522.
135. Aranyó J, Bazan V, Lladós G, Dominguez MJ, Bisbal F, Massanella M, et al.
Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep.
2022;12(1):298.
136. Rass V, Tymoszuk P, Sahanic S, Heim B, Ausserhofer D, Lindner A, et al.
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.
medRxiv. 2022.
137. Sapra A, Malik A, Bhandari P. Vital sign assessment. StatPearls [Internet]:
StatPearls Publishing; 2021.
138. Ross R, Blair SN, Arena R, Church TS, Després JP, Franklin BA, et al.
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case
for Fitness as a Clinical Vital Sign: A Scientific Statement From the American
Heart Association. Circulation. 2016;134(24):e653-e99.
139. Ribeiro Baptista B, d'Humières T, Schlemmer F, Bendib I, Justeau G, Al Assaad L, et al. Identification of factors impairing exercise capacity after severe
COVID-19 pulmonary infection: a 3-month follow-up of prospective
COVulnerability cohort. Respir Res. 2022;23(1):68.
140. Rinaldo RF, Mondoni M, Parazzini EM, Baccelli A, Pitari F, Brambilla E, et al.
Severity does not impact on exercise capacity in COVID-19 survivors. Respir
Med. 2021;187:106577.
141. Mazzucco GA, Torres-Castro R, Intelangelo L, Ortiz BV, Lista-Paz A. Does
COVID-19 Affect the Exercise Capacity of Non-hospitalized Patients? Cureus.
2021;13(9).
86
142. Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A,
et al. Symptoms, pulmonary function, and functional capacity four months after
COVID-19. Annals of the American Thoracic Society. 2021;18(11):1912-7.
143. Finney LJ, Doughty R, Lovage S, Spurr L, Mehta B, Kemp SV, et al. Lung
function deficits and symptom burden in survivors of COVID-19 requiring
mechanical ventilation. Annals of the American Thoracic Society.
2021;18(10):1740-3.
144. Prasannan N, Heightman M, Hillman T, Wall E, Bell R, Kessler A, et al.
Impaired exercise capacity in post-COVID syndrome: the role of VWF ADAMTS13 axis. Blood Advances. 2022.
145. Smith A. Post-viral fatigue: implications for long COVID. Asian Journal of
Research in Infectious Diseases. 2021;6(1):17-23.
146. Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Cancela-Cilleruelo I,
Guerrero-Peral A, Martín-Guerrero JD, García-Azorín D, et al. Post-COVID 19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs
Nonhospitalized Patients. JAMA Netw Open. 2022;5(11):e2242106.
147. Itzhaki RF, Wozniak MA. Viral infection and cognitive decline. J Am Geriatr
Soc. 2007;55(1):131.
148. Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R, Vera-Uribe R,
Sanchez-Ramirez DC, Vasconcello-Castillo L, et al. Assessment of activities of
daily living in patients post COVID-19: a systematic review. PeerJ.
2021;9:e11026.
149. Wright J, Astill SL, Sivan M. The Relationship between Physical Activity and
Long COVID: A Cross-Sectional Study. Int J Environ Res Public Health.
2022;19(9).
150. de Souza FR, Motta-Santos D, Dos Santos Soares D, de Lima JB, Cardozo GG,
Guimarães LSP, et al. Association of physical activity levels and the prevalence
of COVID-19-associated hospitalization. J Sci Med Sport. 2021;24(9):913-8
